Since the outbreak of Corona Virus Disease 2019 (COVID-19) in Hubei province, the epidemic scale has increased rapidly, and no effective antiviral drug therapy has been identified yet. This study aimed to evaluate the adjuvant efficacy of Natural Herbal Medicine (NHM) combined with Western medicine in the treatment of COVID-19. We performed a retrospective, 1:1 matched, case-control study of the first cohort of hospitalized COVID-19-confirmed cases (January 17, 2020 to January 28, 2020). A total of 22 of the 36 confirmed patients were included in this study, split into two groups of 11: the NHM group (NHM combined standard Western medicine treatment) and control group (standard Western medicine treatment alone). All patients received appropriate supportive care and regular clinical and laboratory monitoring. Main evaluation indicators included improvement of clinical symptoms such as fever, cough and diarrhea after hospitalization; pathogen nucleic acid test result of respiratory tract and fecal specimens of the patient after hospitalization, and change of chest CT examination after hospitalization. The duration of fever in the NHM group ( days) was significantly shorter than that in the control group ( days) (). During the whole hospitalization period, the number of cases with diarrhea in the NHM group (two cases) was less than that in the control group (eight cases) (). Compared with the control group (), the duration for improvement (DI) of chest CT in the NHM group () was significantly shorter (). Our results suggest that NHM could improve the clinical symptoms of COVID-19 patients and may be effective in treating COVID-19; thus, a larger, prospective, randomized, controlled clinical trial should be conducted to further evaluate the adjuvant efficacy of NHM in the treatment of COVID-19.
Keywords: Clinical Study; Corona Virus Disease 2019 (COVID-19); Nature Herbal Medicine (NHM); Traditional Chinese Medicine; Treatment Approach.
An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study.Evid Based Complement Alternat Med. 2008 Sep;5(3):355-62. doi: 10.1093/ecam/nem035. Evid Based Complement Alternat Med. 2008. PMID: 18830453 Free PMC article.
[Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease].Zhonghua Yi Xue Za Zhi. 2020 Apr 28;100(16):1223-1229. doi: 10.3760/cma.j.cn112137-20200228-00499. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32157849 Chinese.
[Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1232-1241. doi: 10.19540/j.cnki.cjcmm.20200220.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281330 Chinese.
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17. Chin J Integr Med. 2020. PMID: 32065348 Free PMC article. Review.
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x. Infect Dis Poverty. 2020. PMID: 32183901 Free PMC article. Review.